Cooperman Leon G’s CVS Health CVS Stock Holding History

Cooperman Leon G’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500,000	Closed	-$27M	–	60
2019 Q1	$27M	Buy	+500,000	New	+$30.9M	1.65%	22

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cooperman Leon G's CVS Position: Q2 2019 in Review

Cooperman Leon G sold out of CVS Health (CVS) in Q2 2019, closing a stake of 500,000 shares — an estimated $27M sold.

Cooperman Leon G first reported a position in CVS in Q1 2019 and held it in 1 quarter. The position peaked at $27M in Q1 2019. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

Cooperman Leon G reported no remaining CVS Health position as of Q2 2019 after selling out during the quarter.
Cooperman Leon G sold 500,000 CVS Health shares in Q2 2019, an estimated $27M.
Cooperman Leon G first reported a position in CVS Health in Q1 2019 and held it in 1 quarter.
Cooperman Leon G's CVS Health position peaked at $27M in Q1 2019.
1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Cooperman Leon G's 13F filing for Q2 2019, filed 14 Aug 2019.